112 related articles for article (PubMed ID: 10866382)
1. 9-Benzylpurines with inhibitory activity against Mycobacterium tuberculosis.
Bakkestuen AK; Gundersen LL; Langli G; Liu F; Nolsøe JM
Bioorg Med Chem Lett; 2000 Jun; 10(11):1207-10. PubMed ID: 10866382
[TBL] [Abstract][Full Text] [Related]
2. Synthesis, biological activity, and SAR of antimycobacterial 9-aryl-, 9-arylsulfonyl-, and 9-benzyl-6-(2-furyl)purines.
Bakkestuen AK; Gundersen LL; Utenova BT
J Med Chem; 2005 Apr; 48(7):2710-23. PubMed ID: 15801862
[TBL] [Abstract][Full Text] [Related]
3. Synthesis, structure, and antimycobacterial activity of 6-[1(3H)-isobenzofuranylidenemethyl]purines and analogs.
Braendvang M; Bakken V; Gundersen LL
Bioorg Med Chem; 2009 Sep; 17(18):6512-6. PubMed ID: 19709890
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and antimycobacterial activity of 6-arylpurines: the requirements for the N-9 substituent in active antimycobacterial purines.
Gundersen LL; Nissen-Meyer J; Spilsberg B
J Med Chem; 2002 Mar; 45(6):1383-6. PubMed ID: 11882008
[TBL] [Abstract][Full Text] [Related]
5. Selective anti-tubercular purines: synthesis and chemotherapeutic properties of 6-aryl- and 6-heteroaryl-9-benzylpurines.
Braendvang M; Gundersen LL
Bioorg Med Chem; 2005 Dec; 13(23):6360-73. PubMed ID: 16081292
[TBL] [Abstract][Full Text] [Related]
6. Synthesis, biological activity, and SAR of antimycobacterial 2- and 8-substituted 6-(2-furyl)-9-(p-methoxybenzyl)purines.
Braendvang M; Gundersen LL
Bioorg Med Chem; 2007 Nov; 15(22):7144-65. PubMed ID: 17804243
[TBL] [Abstract][Full Text] [Related]
7. 6-Oxo and 6-thio purine analogs as antimycobacterial agents.
Pathak AK; Pathak V; Seitz LE; Suling WJ; Reynolds RC
Bioorg Med Chem; 2013 Apr; 21(7):1685-95. PubMed ID: 23434367
[TBL] [Abstract][Full Text] [Related]
8. Antimycobacterial agents. 1. Thio analogues of purine.
Pathak AK; Pathak V; Seitz LE; Suling WJ; Reynolds RC
J Med Chem; 2004 Jan; 47(1):273-6. PubMed ID: 14695841
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and biological evaluation of pyrimidine analogs of antimycobacterial purines.
Read ML; Braendvang M; Miranda PO; Gundersen LL
Bioorg Med Chem; 2010 Jun; 18(11):3885-97. PubMed ID: 20488716
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and antimycobacterial activities of non-purine analogs of 6-aryl-9-benzylpurines: Imidazopyridines, pyrrolopyridines, benzimidazoles, and indoles.
Khoje AD; Charnock C; Wan B; Franzblau S; Gundersen LL
Bioorg Med Chem; 2011 Jun; 19(11):3483-91. PubMed ID: 21546254
[TBL] [Abstract][Full Text] [Related]
11. A note on the antitubercular activities of 1-aryl-5-benzylsulfanyltetrazoles.
Adamec J; Waisser K; Kunes J; Kaustová J
Arch Pharm (Weinheim); 2005 Aug; 338(8):385-9. PubMed ID: 16041837
[TBL] [Abstract][Full Text] [Related]
12. Structure-activity relationships on purine and 2,3-dihydropurine derivatives as antitubercular agents: a data mining approach.
Pietra D; Imbriani M; Borghini A; Giorgi I; Settimo FD; Breschi MC; Campa M; Batoni G; Brancatisano FL; Bianucci AM
Chem Biol Drug Des; 2011 Oct; 78(4):718-24. PubMed ID: 21756283
[TBL] [Abstract][Full Text] [Related]
13. Synthesis of non-purine analogs of 6-aryl-9-benzylpurines, and their antimycobacterial activities. Compounds modified in the imidazole ring.
Khoje AD; Kulendrn A; Charnock C; Wan B; Franzblau S; Gundersen LL
Bioorg Med Chem; 2010 Oct; 18(20):7274-82. PubMed ID: 20833056
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and antimycobacterial evaluation of N-substituted 3-aminopyrazine-2,5-dicarbonitriles.
Zitko J; Jampílek J; Dobrovolný L; Svobodová M; Kuneš J; Doležal M
Bioorg Med Chem Lett; 2012 Feb; 22(4):1598-601. PubMed ID: 22281187
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and antimycobacterial activity of 4-[5-(substituted phenyl)-4, 5-dihydro-3-isoxazolyl]-2-methylphenols.
Shaharyar M; Ali MA; Bakht MA; Murugan V
J Enzyme Inhib Med Chem; 2008 Jun; 23(3):432-6. PubMed ID: 18569351
[TBL] [Abstract][Full Text] [Related]
16. 2-Chloro-6-(2-furyl)-9-(4-methoxybenzyl)-9H-purine.
Braendvang M; Gundersen LL
Acta Crystallogr C; 2007 May; 63(Pt 5):o274-6. PubMed ID: 17478910
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and screening of (E)-1-(β-D-galactopyranosyl)-4-(aryl)but-3-ene-2-one against Mycobacterium tuberculosis.
Mugunthan G; Ramakrishna K; Sriram D; Yogeeswari P; Ravindranathan Kartha KP
Bioorg Med Chem Lett; 2011 Jul; 21(13):3947-50. PubMed ID: 21641797
[TBL] [Abstract][Full Text] [Related]
18. Comparative Study of Activities of a Diverse Set of Antimycobacterial Agents against Mycobacterium tuberculosis and Mycobacterium ulcerans.
Scherr N; Pluschke G; Panda M
Antimicrob Agents Chemother; 2016 May; 60(5):3132-7. PubMed ID: 26883701
[TBL] [Abstract][Full Text] [Related]
19. Design, Synthesis, and Biological Evaluation of 1,4-dihydropyridine Derivatives as Potent Antitubercular Agents.
Desai NC; Trivedi AR; Somani HC; Bhatt KA
Chem Biol Drug Des; 2015 Sep; 86(3):370-7. PubMed ID: 25534154
[TBL] [Abstract][Full Text] [Related]
20. Synthesis, antimycobacterial and antifungal evaluation of some new 1-ethyl-5-(hetero)aryl-6-styryl-1,6-dihydropyrazine-2,3-dicarbonitriles.
Verbitskiy EV; Slepukhin PA; Kravchenko MA; Skornyakov SN; Evstigneeva NP; Kungurov NV; Zil'berberg NV; Rusinov GL; Chupakhin ON; Charushin VN
Bioorg Med Chem Lett; 2015 Feb; 25(3):524-8. PubMed ID: 25556103
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
